Sign inJoin waitlistJoin the waitlist

Suphamai Bunnapradist

Nephrology · The Regents of the University of California

Credentials: · · · ·

History

UCLA School of Medicine: Internal Medicine
Until 1999
New England Medical Center
Until 1998
Columbus Hospital
Until 1996
Columbus Hospital
Until 1994
Chulalongkorn University Faculty of Medicine
1990

Research

Cell-Free DNA and Active Rejection in Kidney Allografts
Journal of the American Society of Nephrology · 2017 · 478 citations
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis
Circulation · 2009 · 426 citations
Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies
Systematic review or meta-analysis · American Journal of Transplantation · 2005 · 190 citations

GD
Gabriel Danovitch
43 papers
EH
Edmund Huang
33 papers · 3 as a fellow
Erik Lum
33 papers
Marcelo Sampaio
33 papers · 11 as a resident
Paul Martin
29 papers
Joanna Schaenman
21 papers
PP
Phuong-Thu Pham
21 papers
Stanley Jordan
21 papers · 2 as a fellow
Kamyar Kalantar-Zadeh
20 papers
TS
Tariq Shah
19 papers
ER
Elaine Reed
16 papers
Csaba Kovesdy
13 papers

Grants

Mapping Immune Responses to CMV in Renal Transplant Recipients
National Institute of Allergy and Infectious Diseases · U19
Project lead · $3.4M · University of California Los Angeles
2017–2024
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Responses
Food and Drug Administration · U01
Contact PI · $2.4M · University of California Los Angeles
2014–2018
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $130.8K · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
2003–2007

Clinical trials

Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients
Principal investigator · Completed · Phase 4
University of California, Los Angeles
2018–2021
Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)
Principal investigator · Completed · Phase 4
University of California, Los Angeles
2013–2021
Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
Principal investigator · Completed · Phase 4
University of California, Los Angeles
2009–2011
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
Site PI · Not yet recruiting · Phase 2
Takeda
2026–2029